The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
Liu, G., Friggeri, A., Yang, Y., Milosevic, J., Ding, Q., Thannickal, V. J., Kaminski, N., & Abraham, E. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100035 · Cited by 935 · cited 3×
“These results are consistent with the pathological role of miR-21 in cardiac, lung and renal fibrosis [7, 22, 26].”
BackgroundResultThe Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932
Mouse Models of Diabetic Nephropathy
Brosius, F. C., Alpers, C. E., Bottinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 895
Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652
Self-citationRoy, S., Khanna, S., Hussain, S.-R. A., Biswas, S., Azad, A., Rink, C., Gnyawali, S., Shilo, S., Nuovo, G. J., & Sen, C. K. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp015 · Cited by 614
In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes
Kloosterman, W. P., Wienholds, E., de Bruijn, E., Kauppinen, S., & Plasterk, R. H. A. (2006) · Nature Methods · doi:10.1038/nmeth843 · Cited by 599
Diabetic Nephropathy: Mechanisms of Renal Disease Progression
Kanwar, Y. S., Wada, J., Sun, L., Xie, P., Wallner, E. I., Chen, S., Chugh, S., & Danesh, F. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0705-mr-134 · Cited by 596
MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
Chau, B. N., Xin, C., Hartner, J., Ren, S., Castano, A. P., Linn, G., Li, J., Tran, P. T., Kaimal, V., Huang, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003205 · Cited by 587
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Qin, W., Chung, A. C. K., Huang, X. R., Meng, X.-M., Hui, D. S. C., Yu, C.-M., Sung, J. J. Y., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121308 · Cited by 566
Self-citationMouse Models of Diabetic Nephropathy
Breyer, M. D., Bo[Combining Diaeresis]ttinger, E., Brosius, F. C., Coffman, T. M., Harris, R. C., Heilig, C. W., & Sharma, K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080648 · Cited by 467
Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator
Ziyadeh, F. N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093460.24823.5b · Cited by 463
Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis
Zhong, X., Chung, A. C. K., Chen, H.-Y., Meng, X.-M., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111168 · Cited by 409
Self-citationIdentification of a microRNA signature of renal ischemia reperfusion injury
Godwin, J. G., Ge, X., Stephan, K., Jurisch, A., Tullius, S. G., & Iacomini, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912701107 · Cited by 373
miR-192 Mediates TGF-β/Smad3-Driven Renal Fibrosis
Chung, A. C. K., Huang, X. R., Meng, X., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020134 · Cited by 354
Self-citationLan, H. Y., Mu, W., Tomita, N., Huang, X. R., Li, J. H., Zhu, H.-J., Morishita, R., & Johnson, R. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000067632.04658.b8 · Cited by 344
Self-citationLu, T. X., Hartner, J., Lim, E.-J., Fabry, V., Mingler, M. K., Cole, E. T., Orkin, S. H., Aronow, B. J., & Rothenberg, M. E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101235 · Cited by 341
Merline, R., Moreth, K., Beckmann, J., Nastase, M. V., Zeng-Brouwers, J., Tralhão, J. G., Lemarchand, P., Pfeilschifter, J., Schaefer, R. M., Iozzo, R. V., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001868 · Cited by 333
MicroRNA-21: A novel therapeutic target in human cancer
Pan, X., Wang, Z.-X., & Wang, R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.12.14252 · Cited by 322
Roggli, E., Britan, A., Gattesco, S., Lin-Marq, N., Abderrahmani, A., Meda, P., & Regazzi, R. (2010) · Diabetes · doi:10.2337/db09-0881 · Cited by 317
Diabetes Complications: The MicroRNA Perspective
Kantharidis, P., Wang, B., Carew, R. M., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db11-0082 · Cited by 289
Self-citationIdentification of a microRNA signature in renal fibrosis: role of miR-21
Zarjou, A., Yang, S., Abraham, E., Agarwal, A., & Liu, G. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00273.2011 · Cited by 241
Signaling Mechanism of TGF-β1 in Prevention of Renal Inflammation: Role of Smad7
Wang, W., Huang, X. R., Li, A. G., Liu, F., Li, J.-H., Truong, L. D., Wang, X. J., & Lan, H. Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121070 · Cited by 236
Self-citationDey, N., Das, F., Mariappan, M. M., Mandal, C. C., Ghosh-Choudhury, N., Kasinath, B. S., & Choudhury, G. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208066 · Cited by 226
The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
Chen, H. Y., Huang, X. R., Wang, W., Li, J. H., Heuchel, R. L., Chung, A. C. K., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db10-0403 · Cited by 225
Self-citationMicroRNA-21 targets the vitamin D–dependent antimicrobial pathway in leprosy
Liu, P. T., Wheelwright, M., Teles, R., Komisopoulou, E., Edfeldt, K., Ferguson, B., Mehta, M. D., Vazirnia, A., Rea, T. H., Sarno, E. N., et al. (2012) · Nature Medicine · doi:10.1038/nm.2584 · Cited by 206
Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse
Yaswen, L., Kulkarni, A., Fredrickson, T., Mittleman, B., Schiffman, R., Payne, S., Longenecker, G., Mozes, E., & Karlsson, S. (1996) · Blood · doi:10.1182/blood.v87.4.1439.bloodjournal8741439 · Cited by 204
Advanced Glycation End-Products Induce Tubular CTGF via TGF-β–Independent Smad3 Signaling
Chung, A. C. K., Zhang, H., Kong, Y.-Z., Tan, J.-J., Huang, X. R., Kopp, J. B., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010018 · Cited by 180
Self-citationChung, A. C. K., Huang, X. R., Zhou, L., Heuchel, R., Lai, K. N., & Lan, H. Y. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn699 · Cited by 175
Self-citationInflammatory mechanisms of diabetic complications
Williams, M. D., & Nadler, J. L. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0038-y · Cited by 170
MicroRNA‐21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice
Zhang, Z., Peng, H., Chen, J., Chen, X., Han, F., Xu, X., He, X., & Yan, N. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.05.021 · Cited by 168
Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis
Fu, X., Han, Y., Wu, Y., Zhu, X., Lü, X., Mao, F., Wang, X., He, X., Zhao, Y., & Zhao, Y. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02535.x · Cited by 167
microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis
Noetel, A., Kwiecinski, M., Elfimova, N., Huang, J., & Odenthal, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00049 · Cited by 163
Role of TGF-β signaling in extracellular matrix production under high glucose conditions
Li, J., Huang, X. R., Zhu, H., Johnson, R. J., & Lan, H. Y. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00016.x · Cited by 160
Self-citationArakawa, K., Ishihara, T., Oku, A., Nawano, M., Ueta, K., Kitamura, K., Matsumoto, M., & Saito, A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703829 · Cited by 160
Hou, C., Wang, W., Huang, X. R., Fu, P., Chen, T.-H., Sheikh‐Hamad, D., & Lan, H. Y. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62297-3 · Cited by 158
Self-citationDiabetic nephropathy: Important pathophysiologic mechanisms
Soldatos, G., & Cooper, M. E. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.042 · Cited by 143
Smad7 Gene Therapy Ameliorates an Autoimmune Crescentic Glomerulonephritis in Mice
Ka, S., Huang, X., Lan, H.-Y., Tsai, P., Yang, S., Shui, H., & Chen, A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080901 · Cited by 123
Self-citationLim, A. K. H., Ma, F. Y., Nikolic‐Paterson, D. J., Thomas, M. C., Hurst, L., & Tesch, G. H. (2009) · Diabetologia · doi:10.1007/s00125-009-1399-3 · Cited by 102
Prevention of decline in renal function in the diabetic db/db mouse
Cohen, M. P., Clements, R. S., Cohen, J. A., & Shearman, C. W. (1996) · Diabetologia · doi:10.1007/bf00418341 · Cited by 54
Cited by
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Self-citationCKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Anders, H.-J., Huber, T. B., Isermann, B., & Schiffer, M. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0001-y · Cited by 796
TGF-β/Smad signaling in renal fibrosis
Meng, X.-M., Tang, P. M.-K., Li, J., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00082 · Cited by 666
Self-citationEpigenetics and epigenomics in diabetic kidney disease and metabolic memory
Kato, M., & Natarajan, R. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 600
Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response
Sheedy, F. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00019 · Cited by 496
Metadata
- Authors
- Zhong, X., Chung, A. C. K., Chen, H. Y., Dong, Y., Meng, X. M., Li, R., Yang, W., Hou, F. F., & Lan, H. Y.
- Venue
- Diabetologia
- Published
- 2013-01-05
- Volume
- 56
- Issue
- 3
- Pages
- 663-674
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2030339637
- Cited by
- 355
- References
- 41
- FWCI
- 25.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.